Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

24.2 Antitussives

Pharmacology for Nurses24.2 Antitussives

By the end of this section, you should be able to:

  • 24.2.1 Identify the characteristics of antitussive drugs used to treat respiratory disorders.
  • 24.2.2 Explain the indications, actions, adverse reactions, and interactions of antitussive drugs used to treat respiratory disorders.
  • 24.2.3 Describe nursing implications of antitussive drugs used to treat respiratory disorders.
  • 24.2.4 Explain the client education related to antitussive drugs used to treat respiratory disorders.

Opioid Antitussives

Antitussives are drugs that are used to treat nonproductive coughs. They are more commonly referred to as cough suppressants. Although their exact mechanism of action is unknown, it is thought that these medications inhibit the cough center in the brain or soothe nerve receptors around airways to reduce transmission of cough signals to the brain. Antitussives are not recommended for productive coughs where the client is coughing up mucus due to the infection risk that can result from the buildup of mucus in the respiratory system. Many antitussives are available over the counter, but there are a few that are prescription only (Sison, 2022).

Opioid antitussives are very effective and are thought to act centrally in the brain stem as well as on sensory nerve endings in the airways. The main concern with opioid antitussives is the potential for dependence, respiratory depression, and gastrointestinal issues such as constipation. Due to the opioid component, addiction is a concern, as is overdose of the drug.

Codeine/Guaifenesin

Codeine/guaifenesin is an opioid drug that is very effective as an antitussive, or cough suppressant. The drug works by suppressing the cough reflex through direct action on the cough center in the medulla. Because it contains codeine, which is an opioid, there is concern about adverse effects such as respiratory depression and dependence (MedlinePlus, 2023).

Adverse Effects and Contraindications

Opioid antitussives can cause drowsiness, dizziness, confusion, and hypotension. Dependence is also a concern due to the opioid portion. Those who are hypersensitive to them should avoid their use. Clients with angle-closure glaucoma, pyloric stenosis, peptic ulcer disease, and prostatic hyperplasia should also avoid opioid antitussives.

Table 24.10 is a drug prototype table for opioid antitussives featuring codeine/guaifenesin. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Opioid antitussive

Mechanism of Action
Acts on the cough center in the medulla to suppress the cough reflex
Drug Dosage
20 mg orally every 4 hours as needed.
Indications
Nonproductive cough, especially chronic cough

Therapeutic Effects
Reduces coughing episodes
Drug Interactions
Other CNS depressants
Benzodiazepines
Bupropion
Macrolide antibiotics
Muscle relaxers
Serotonergic drugs
St. John’s wort

Food Interactions
Alcohol
Adverse Effects
Drowsiness
Dizziness
Confusion
Hypotension
Constipation
Respiratory depression
Contraindications
Hypersensitivity

Caution:
Angle-closure glaucoma
Stenosing peptic ulcer
Prostatic hyperplasia
Table 24.10 Drug Prototype Table: Codeine/Guaifenesin (source: https://dailymed.nlm.nih.gov/dailymed/)

Nonopioid Antitussives

Nonopioid antitussives are antitussives that do not contain an opioid component. Because of the lack of an opioid, there are no opioid-related side effects. These drugs work by numbing the throat and suppressing the cough. Drowsiness, dizziness, headache, and trouble sleeping are common side effects of these drugs.

Benzonatate

Benzonatate is a nonopioid antitussive that works by reducing the cough reflex in the airways and lungs. The drug comes as a capsule, taken orally. Clients should discuss with their health care provider any medications they are currently taking and inform the provider immediately if they experience rash, itching, or confusion because these are adverse effects (MedlinePlus, 2017).

Dextromethorphan

Dextromethorphan acts to suppress cough by acting on the cough center in the medulla. This drug is a common choice for relief of cough because it does not cause addiction and has little to no CNS depression. Clients should inform their health care provider if their cough lasts longer than 1 week or is accompanied by other symptoms such as fever or rash.

Table 24.11 lists common nonopioid antitussives and typical routes and dosing for adult clients.

Drug Routes and Dosage Ranges
Benzonatate
(Tessalon)
One 100 mg or one 200 mg capsule orally 3 times daily as needed. Maximum dose: 600 mg/day.
Dextromethorphan
(Robitussin)
15 mg orally every 4 hours as needed. Maximum dose: 120 mg/day.
Table 24.11 Drug Emphasis Table: Nonopioid Antitussives (source: https://dailymed.nlm.nih.gov/dailymed/; MedlinePlus, 2017)

Adverse Effects and Contraindications

Adverse effects of nonopioid antitussives include rash, itching, confusion, nausea, and constipation. Some clients may also experience lightheadedness, dizziness, and drowsiness. Clients with a hypersensitivity to nonopioid antitussives should avoid their use, and they should be used with caution in clients who are sedated or must remain supine.

Table 24.12 is a drug prototype table for the nonopioid antitussives featuring dextromethorphan. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Nonopioid antitussive

Mechanism of Action
Main action is not well known, but thought to act on the site in the brain stem that acts as the gate for the cough reflex
Drug Dosage
15 mg orally every 4 hours as needed. Maximum dose: 120 mg/day.
Indications
Nonproductive coughs

Therapeutic Effects
Temporarily relieves cough caused by throat and bronchial irritation due to colds or allergies
Drug Interactions
MAOIs

Food Interactions
Grapefruit juice
Adverse Effects
Drowsiness
Dizziness
Confusion
Nausea
Vomiting
Contraindications
Hypersensitivity
Children under age 4

Caution:
Clients who are sedated or must remain in a supine position (these clients may have an inability to clear their airway appropriately)
Table 24.12 Drug Prototype Table: Dextromethorphan (source: https://dailymed.nlm.nih.gov/dailymed/)

Safety Alert

Antitussives and Older Adults

Opioid antitussive doses may need to be reduced in older adults. Older adults are more sensitive to opioids and more likely to have adverse reactions.

Clinical Tip

Antitussive Education

When educating clients on use of antitussives, the nurse should tell them to call their health care provider if their cough last for more than 1 week, worsens, or is accompanied by other symptoms such as a headache that will not go away, a fever, or a rash. These may indicate a more serious medical condition.

Special Considerations

Antitussives

Opioid antitussives can cause respiratory depression. Respirations should be monitored closely.

Antitussives can cause drowsiness, and clients should avoid driving until they know how the drug will affect them.

Antitussives should not be taken longer than recommended to prevent serious adverse effects.

(Source: Nurselabs, 2023)

Nursing Implications

The nurse should do the following for clients who are taking antitussives:

  • Prior to administering, assess the client’s medical history, current drug list, and allergies for potential interactions and contraindications.
  • Prior to administering, assess the client’s respiratory status for signs of respiratory distress that indicate additional evaluation and treatment is indicated.
  • Assess and monitor the client’s cough including type and frequency.
  • Educate the client on adverse effects of antitussives including drowsiness, dizziness, constipation (opioid antitussives), and nausea and vomiting (nonopioid antitussives).
  • For clients taking opioid antitussives, monitor vital signs for hypotension and respiratory depression before and after administration.
  • For clients taking opioid antitussives, monitor for misuse or abuse.
  • For clients taking opioid antitussives, the nurse should instruct the client on how to maintain healthy bowel habits to avoid constipation.
  • Initiate fall precautions for older clients due to the adverse effects of hypotension, dizziness, and drowsiness (opioid antitussives).
  • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

Client Teaching Guidelines

The client taking an antitussive should:

  • Take the medication as prescribed and should not exceed recommended doses.
  • Report a cough that lasts longer than 1 week or is accompanied by other symptoms.
  • Report symptoms of respiratory depression.
  • Take measures to prevent constipation.
  • Keep all antitussives out of the reach of children.
  • Avoid irritants, such as smoking, that can cause more coughing.
  • Increase fluid intake to help loosen secretions.

FDA Black Box Warning

Antitussives

Antitussives containing codeine have a high risk of addiction, abuse, and misuse.

Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.